Constrained Evolution of Human Immunodeficiency Virus Type 1 Protease during Sequential Therapy with Two Distinct Protease Inhibitors

Eitemau Tebyg

• Effects of Human Immunodeficiency Virus Type 1 Resistance to Protease Inhibitors on Reverse Transcriptase Processing, Activity, and Drug Sensitivity
  gan: de la Carrière, Laurence Carron, et al.
  Cyhoeddwyd: (1999)
• Role of Minority Populations of Human Immunodeficiency Virus Type 1 in the Evolution of Viral Resistance to Protease Inhibitors
  gan: Charpentier, Charlotte, et al.
  Cyhoeddwyd: (2004)
• Structural Basis for Distinctions between Substrate and Inhibitor Specificities for Feline Immunodeficiency Virus and Human Immunodeficiency Virus Proteases
  gan: Lin, Ying-Chuan, et al.
  Cyhoeddwyd: (2003)
• Selective-Advantage Profile of Human Immunodeficiency Virus Type 1 Integrase Mutants Explains In Vivo Evolution of Raltegravir Resistance Genotypes
  gan: Quercia, Romina, et al.
  Cyhoeddwyd: (2009)
• Kinetics of Antiviral Activity and Intracellular Pharmacokinetics of Human Immunodeficiency Virus Type 1 Protease Inhibitors in Tissue Culture
  gan: Nascimbeni, Michelina, et al.
  Cyhoeddwyd: (1999)